|
INTI Inhibitor Therapeutics Inc 1042418 |
| Income Statement |
|
Net Income
|
form10-q
|
-730,957 |
| Balance Sheet |
|
Current Assets
|
6,451,442 |
|
Assets
|
6,451,442 |
|
Current Liabilities
|
44,559 |
|
Liabilities
|
3,044,559 |
|
Equity
|
3,406,883 |
|
Shares Out
|
172,324,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-2,461,608 |
| Market Analysis |
Market Cap
|
14,647,497 |
|
Price
|
0.07 |
|
BVPS
|
0.02 |
|
PB
|
3.54 |
|
EPS
|
-0.02 |
|
PS
|
853.65 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view INTI documents filed with the SEC.
INTI Filings
Clear
